Search

  • HOME
  • Search
Original Article
1604
The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients
Yu Jun Wong, Prem Harichander Thurairajah, Rahul Kumar, Kwong Ming Fock, Ngai Moh Law, Sin-Yoong Chong, Fria Gloriba Manejero, Tiing-Leong Ang, Eng Kiong Teo, Jessica Tan
Clin Mol Hepatol. 2021;27(3):474-485.   Published online February 19, 2021
1577
Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysis
Po-Yao Hsu, Yu-Ju Wei, Jia-Jung Lee, Sheng-Wen Niu, Jiun-Chi Huang, Cheng-Ting Hsu, Tyng-Yuan Jang, Ming-Lun Yeh, Ching-I Huang, Po-Cheng Liang, Yi-Hung Lin, Ming-Yen Hsieh, Meng-Hsuan Hsieh, Szu-Chia Chen, Chia-Yen Dai, Zu-Yau Lin, Shinn-Cherng Chen, Jee-Fu Huang, Jer-Ming Chang, Shang-Jyh Hwang, Wan-Long Chuang, Chung-Feng Huang, Yi-Wen Chiu, Ming-Lung Yu
Clin Mol Hepatol. 2021;27(1):186-196.   Published online December 3, 2020
1565
Efficacy and safety of ledipasvir/sofosbuvir in 5,028 Mongolian patients infected with genotype 1 hepatitis C virus: A multicenter study
Oidov Baatarkhuu, Jae Seung Lee, Jazag Amarsanaa, Do Young Kim, Sang Hoon Ahn, Nyamsuren Naranzul, Damba Enkhtuya, Nagir Choijamts, Purev Batbayar, Radnaa Otgonbayar, Bat-Ulzii Saruul, Chuluunbaatar Gantuul, Baljinnyam Gegeebadrakh, Narangerel Tuvshinbayar, Dorjgotov Badamsuren, Galsan Ulzmaa, Jamiyandorj Otgonbold, Kwang-Hyub Han
Clin Mol Hepatol. 2021;27(1):125-135.   Published online November 27, 2020
Elimination of hepatitis C: What would be the practical approach?
Hyung Joon Yim
Clin Mol Hepatol. 2021;27(1):97-99.   Published online December 3, 2020
Original Article
Trends in the prevalence of chronic liver disease in the Korean adult population, 1998–2017
Seung Ha Park, Lindsay D. Plank, Ki Tae Suk, Yong Eun Park, Jin Lee, Joon Hyuk Choi, Nae Yun Heo, Jongha Park, Tae Oh Kim, Young Soo Moon, Hyun Kuk Kim, Hang Jea Jang, Ha Young Park, Dong Joon Kim
Clin Mol Hepatol. 2020;26(2):209-215.   Published online November 4, 2019
Influence of some methylated hepatocarcinogenesis-related genes on the response to antiviral therapy and development of fibrosis in chronic hepatitis C patients
Waleed Seif Eldin Mohamed Mostafa, Mohammed Hassan Saiem Al-Dahr, Dalia Abdel Hamid Omran, Zeinab Fathy Abdullah, Suzan Hamdy Elmasry, Mohamed Nabil Ibrahim
Clin Mol Hepatol. 2020;26(1):60-69.   Published online October 22, 2019
An integrated analysis of elbasvir/grazoprevir in Korean patients with hepatitis C virus genotype 1b infection
Youn Jae Lee, Jeong Heo, Do Young Kim, Woo Jin Chung, Won Young Tak, Yoon Jun Kim, Seung Woon Paik, Eungeol Sim, Susila Kulasingam, Rohit Talwani, Barbara Haber, Peggy Hwang
Clin Mol Hepatol. 2019;25(4):400-407.   Published online May 28, 2019
1435
Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients
Christian Mölleken, Maike Ahrens, Anders Schlosser, Julia Dietz, Martin Eisenacher, Helmut E. Meyer, Wolff Schmiegel, Uffe Holmskov, Christoph Sarrazin, Grith Lykke Sorensen, Barbara Sitek, Thilo Bracht
Clin Mol Hepatol. 2019;25(1):42-51.   Published online November 19, 2018
1343
Efficacy and safety of daclatasvir plus asunaprevir for Korean patients with HCV genotype Ib infection: a retrospective multi-institutional study
Byeong Wook Cho, Seok Bae Kim, Il Han Song, Sae Hwan Lee, Hong Soo Kim, Tae Hee Lee, Young Woo Kang, Seok Hyun Kim, Byung Seok Lee, Hee Bok Chae
Clin Mol Hepatol. 2017;23(1):51-56.   Published online March 16, 2017
The Korean Journal of Hepatology Elsewhere
Role of vitamin D in chronic hepatitis C
Tae Yeob Kim
Clin Mol Hepatol. 2011;17(2):170-172.   Published online June 23, 2011
4
Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C
Yun Nah Lee, M.D., Soung Won Jeong, M.D., Jae Hee Lim, M.D., Yang Seon Ryu, M.D., Seong Ran Jeon, M.D., Sang Kyun Kim, M.D., Jae Young Jang, M.D., Young Seok Kim, M.D., Boo Sung Kim, M.D., Mi Oh Roh, M.D.
Clin Mol Hepatol. 2010;16(2):187-191.   Published online June 25, 2010
A Case of Vasculitis in Chronic Hepatitis C Patient Treated with Pegylated Interferon Alpha-2a and Ribavirin
Youn Ho Kim , Woo Sik Han , Sun Jae Lee , Sung Nam Oh , Do Won Choi , Kwan Soo Byun , Jong Eun Yeon
Clin Mol Hepatol. 2007;13(3):419-422.   Published online September 20, 2007
1
Treatment of Chronic Hepatitis C: Shorter Treatment Duration For Genotype 2 or 3 Infection
Sook Hyang Jeong
Clin Mol Hepatol. 2007;13(3):301-303.   Published online September 20, 2007
4
Pulmonary Toxicity by Pegylated Interferon α-2a in a Patient with Chronic Hepatitis C
Byoung Kwan Son , Joo Hyun Sohn , Tae Yeob Kim , Yoon Kyung Park , Yong Chul Jeon , Dong Soo Han
Clin Mol Hepatol. 2007;13(1):103-107.   Published online January 1, 1970
3
Clinical Significance of Intrahepatic HCV RNA Level in Chronic HCV Infection
Jae Young Jang, M.D., Yun Soo Kim, M.D. Sang Gyune Kim, M.D., Young Seok Kim, M.D., Young Deok Cho, M.D., Joon Sung Lee, M.D., So Young Jin, M.D. Moon Sung Lee, M.D., Ju Hyun Kim, M.D. Chan Sup Shim, M.D., and Boo Sung Kim, M.D.
Clin Mol Hepatol. 2006;12(4):515-523.   Published online January 1, 1970
2
Immunology of Hepatitis C: Clinical Significance of T Cell Response
Eui Cheol Shin
Clin Mol Hepatol. 2006;12(2):140-153.   Published online January 1, 1970
1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 242
TOTAL : 617915
Close layer